The model suggested that the Wnt pathway inhibitor, Dickhopf1 (Dkk1), was the QS molecule in breast cancer, and that high levels of this protein will drive BCSCs into differentiation, leading to tumor elimination. Here, DKK1 is linked to breast cancer.